Literature DB >> 3615807

Mechanism of growth retardation of the adenocarcinoma EO 771.

I D Bassukas, B Maurer-Schultze.   

Abstract

Growth retardation of tumors has been predominantly described by an increase of the "cell loss factor" phi. However, this cell loss factor alone merely reflects the growth deceleration without giving information on the mechanism that causes growth retardation. In the present study a quantitative analysis of the mechanism causing growth retardation of the adenocarcinoma EO 771 has been carried out by determining separately the components of the cell loss factor phi, namely the cell production rate and the cell loss rate of the tumor cell population. For this purpose the alteration of the histology of the tumor (proportion of necrotic tumor tissue, tumor cell density) and the proliferative capacity of the tumor cell population as a function of the tumor size was studied by applying morphometric and cell kinetic methods. The results show that growth deceleration is due to a decrease of the cell production rate kappa p and a simultaneous increase of the cell loss rate kappa l. Both processes contribute to about the same extent to the growth deceleration of the tumor cell population. In early tumor growth deceleration is mainly due to a prolongation of the cycle time of the tumor cells, in later phases of tumor growth to an increasing probability of the tumor cells to decycle leading to a decrease of the growth fraction GF and an increase of the cell loss rate kappa l.

Entities:  

Mesh:

Year:  1987        PMID: 3615807     DOI: 10.1007/bf01211407

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  37 in total

1.  Caffeine inhibition of postreplication repair of N-acetoxy-2-acetylaminofluorene-damaged DNA in Chinese hamster cells.

Authors:  L Simpson-Herren; D P Griswold
Journal:  Cancer Res       Date:  1973-10       Impact factor: 12.701

2.  Kinetic parameters and growth curves for experimental tumor systems.

Authors:  L Simpson-Herren; H H Lloyd
Journal:  Cancer Chemother Rep       Date:  1970-06

3.  Growth kinetics of small cell carcinoma of the lung.

Authors:  R E Lenhard; K B Woo; J S Freund; M D Abeloff
Journal:  Eur J Cancer Clin Oncol       Date:  1981-08

4.  Vascular volume and perfusion in hamster cheek pouch carcinomas and tumor-bearing cheek pouches.

Authors:  A G Lurie; B B Nintzel; R M Rippey
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

5.  Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor.

Authors:  I F Tannock
Journal:  Cancer Res       Date:  1970-10       Impact factor: 12.701

6.  Cell proliferation in human melanoma.

Authors:  S Shirakawa; J K Luce; I Tannock; E Frei
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

7.  Cytokinetics of tumour and endothelial cells and vascularization of lung metastases in C3H/He mice.

Authors:  N Gunduz
Journal:  Cell Tissue Kinet       Date:  1981-07

8.  The cell population kinetics and response to an S-phase specific agent of three transplantable colon tumor lines.

Authors:  L Simpson-Herren; T H Corbett; D P Griswold
Journal:  Cell Tissue Kinet       Date:  1980-11

Review 9.  L.H. Gray Medal lecture: cell kinetics and radiation oncology.

Authors:  M Tubiana
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-09       Impact factor: 7.038

10.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies.

Authors:  B Hobson; J Denekamp
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more
  7 in total

1.  Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.

Authors:  B Maurer-Schultze; I D Bassukas; M Böswald; M Harasim
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.

Authors:  Petr Pančoška; Lubomír Skála; Jaroslav Nešetřil; Brian I Carr
Journal:  Semin Oncol       Date:  2015-01-05       Impact factor: 4.929

3.  Evidence for a narrow range of growth patterns of malignant tumors and embryos of different species.

Authors:  I D Bassukas
Journal:  Naturwissenschaften       Date:  1993-08

4.  Growth of metastases of the mouse adenocarcinoma EO 771: an allometric relationship between growth of the primary tumors and their metastases.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

5.  Tumor cell recruitment in the mouse adenocarcinoma EO 771 directly demonstrated by double labeling with [3H]- and [14C] thymidine and flow cytometry.

Authors:  J Walter; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Analysis of volumetric response of pituitary adenomas receiving adjuvant CyberKnife stereotactic radiosurgery with the application of an exponential fitting model.

Authors:  Yi-Lin Yu; Yun-Ju Yang; Chin Lin; Chih-Chuan Hsieh; Chiao-Zhu Li; Shao-Wei Feng; Chi-Tun Tang; Tzu-Tsao Chung; Hsin-I Ma; Yuan-Hao Chen; Da-Tong Ju; Dueng-Yuan Hueng
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

7.  Analysis of inter-patient variations in tumour growth rate.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson
Journal:  Theor Biol Med Model       Date:  2014-05-20       Impact factor: 2.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.